MPNRF Blog

Health Activist and Blogger Takes on a Month Long Writing Challenge With a Focus on ET

During the month of April, blogger Lina will be participating in WEGO Health’s #hawmc. The Health Activist Writer’s Month Challenge will have her writing every day during the month of April. Themes will be based on suggestions from WEGO Health. [...]

CONTINUE READING

2015 MPN Challenge Grant Program

The 2015 MPN Challenge is a grant program supported jointly by the MPN Research Foundation and the Leukemia & Lymphoma Society. This grant program represents an important partnership between MPNRF and LLS, who share a mission to advance the scientific understanding of MPNs and bring new treatments and the hope for a cure to patients with these rare diseases. [...]

CONTINUE READING

Research Fuels Progress Against Cancer

Research continues to be our best defense against cancer. It improves survival and quality of life for millions of people by spurring the development of new and better ways to prevent, detect, diagnose, treat, and, increasingly, cure some of the more than 200 diseases we call cancer. [...]

CONTINUE READING

FDA Issues Verbal Hold for Geron's Imetelstat Application

Geron has been given verbal notification from the U.S. Food and Drug Administration (FDA) that its application for imetelstat has been placed on full clinical hold, affecting all ongoing company-sponsored clinical trials. A full clinical hold is an order that the FDA issues to a trial sponsor to suspend an ongoing clinical trial or delay a proposed trial. [...]

CONTINUE READING

Crafting the MPN Environment

The World Orphan Drug Congress recently put out an independent study of the most researched rare diseases. We were shocked to see that the MPNs (MPDs on the list) ranked No. 10 of 25.  [...]

CONTINUE READING
<< Previous  |  Next >>

About the Blog

Check back regularly for updates about what’s happening in the MPN community, from advocacy to research..

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe